[1] |
ZOU Yuanlei, XIA Qingrong, LIANG Jun, HE Kongliang, MO Daming, WU Wenning.
Words of Warning and Preventive Measures in Labels of Antidepressants
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 329-333.
|
[2] |
LIU Biqing, ZHANG Xiaotong, WANG Ke, XING Xiaoxuan, WANG Zhizhou, ZHUANG Wei, ZHANG Qingxia, ZHANG Lan, LI Xiaoling, DONG Xianzhe.
Adverse Drug Reaction in 385 Elderly Inpatients with Bacterial Pneumonia under Polypharmacy
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 206-210.
|
[3] |
LIU Jie, ZHANG Jianmin, ZHANG Xiaomeng, LIU Fang, SONG Yuan, ZHONG Xuli.
Management of risks to pediatric medications based on drug instructions of Chinese patent medicines in a hospital
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 422-427.
|
[4] |
ZHANG Jian, FANG Huihua.
Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189.
|
[5] |
ZHANG Qingxia, JIANG Yongxian, DONG Yuexin, XIAN Ying, YAN Suying.
Risk analysis and precautions related to storage conditions specified in package inserts of western medicines in a hospital
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 913-918.
|
[6] |
ZHAO Jianbin, HUANG Yuling.
Risks and applications of parecoxib for injection based on drug instructions and judgment documents
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1250-1253.
|
[7] |
ZHAO Shuang, GU Rui, SONG Yanqing, WANG Xiangfeng, MIAO Qiuli.
Information Labeling in Instructions of Anti-tumor Drugs for Intravenous Infusion in a Hospital
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(10): 978-980.
|
[8] |
WENG Lihong, GAO Huan, HU Xue, ZHANG Wenrui.
Infusion Requirements on Labels of 39 Chinese Traditional Medicine Injections
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(7): 437-440.
|
[9] |
LIU Min, HU Xue, LI Yanjiao, SONG Yanqing, WANG Xiangfeng.
Labeling of Instructions for Biopharmaceuticals for Intravenous Infusion
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(3): 165-168.
|
[10] |
YU Chengxuan, GUO Daihong, YAO Chong, YANG Hongyi, ZHU Yu, LIU Siyuan, KONG Xianghao.
968 Cases of Drug-induced Kidney Injury and Risk Signal Mining of Anti-infective Drugs
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(12): 894-899.
|
[11] |
ZHAO Shuang, SONG Yanqing, WANG Xiangfeng, JINFang, MIAO Qiuli.
Analysis of Pediatric Use Information in Package Inserts of Antineoplastic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 555-560.
|
[12] |
LI Lan, XIA Dongsheng, TIAN Chunhua, PENG Lili, GAO Yunjuan.
Analysis and Consideration on Safety Risk of Thiamazole Tablets
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(7): 393-397.
|
[13] |
WANGYan-li.
Investigation and Analysis of 40 Groups of Injection Drugs in Our Hospital
[J]. Chinese Journal of Pharmacovigilance, 2018, 15(3): 147-151.
|
[14] |
ZENG Jing ,ZHUO Lin ,ZHAN Si-yan*.
Comparison and Analysis on Instructions for Foreign and Domestic Aspirin Enteric-coated Tablets
[J]. Chinese Journal of Pharmacovigilance, 2015, 12(5): 271-274.
|